Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Net Income of -$226.3 thousand for fiscal year 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$226.3K | -130.1% |
| 2023 | $751.6K | +204.4% |
| 2022 | -$720.1K | -46.7% |
| 2021 | -$491.0K | — |
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed a decrease of -130.1% in Net Income compared to the prior fiscal year.
- Over the 2021–2024 period, Cordyceps Sunshine Biotech Holdings Co., Ltd.’s net income has grown by 53.9% (from -$491.0 thousand to -$226.3 thousand).
- The most recent figure is from Cordyceps Sunshine Biotech Holdings Co., Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 13, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: